We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Switching Cholesterol Drugs May Be Fatal: Study

Law360 (September 5, 2007, 12:00 AM EDT) -- A new study backed by Pfizer Inc. suggests that patients switching from Pfizer's cholesterol-lowering drug Lipitor to zimvastin, a generic version of Merck & Co.'s Zocor, are 30% more likely to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.